Aprea Therapeutics, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 03836J102 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Squadron Capital Management LLC 13G	9.9%	1,271,081	13G	4/7/2026 Event 3/30/2026
Squadron Master Fund LP	9.9%	1,271,081
Squadron Capital Management LLC	9.9%	1,271,081
William Blank	9.9%	1,271,081
Matthew Sesterhenn	9.9%	1,271,081
Orin Hirschman 13G/A	9.9%	1,186,294	13G/A	4/27/2026 Event 3/31/2026
Orin Hirschman	9.9%	1,186,294
AIGH Capital Management LLC	9.9%	1,186,294
Sio Capital Management, LLC 13G/A	5.1%	276,603	13G/A	2/10/2025 Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Soleus Private Equity Fund III, L.P. 13G	10.0% Checked 5% or less	1,271,080	13G	4/1/2026 Event 4/1/2026
Soleus Private Equity Fund III, L.P.	10.0%	1,271,080
Soleus Private Equity GP III, LLC	10.0%	1,271,080
Soleus PE GP III, LLC	10.0%	1,271,080
Soleus Capital Master Fund, L.P.	10.0%	1,271,080
Soleus Capital, LLC	10.0%	1,271,080
Soleus Capital Group, LLC	10.0%	1,271,080
Soleus Capital Management, L.P.	10.0%	1,271,080
Soleus GP, LLC	10.0%	1,271,080
Guy Levy	10.0%	1,271,080

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q2	1	0	$0	$0
2025 Q1	1	0	$0	$0
2024 Q4	1	0	$0	$0
2024 Q3	2	899	$2.00 k	$0
2024 Q2	2	899	$3.00 k	$0
2024 Q1	3	999	$675.00	$0
2023 Q4	2	100	$470.00	$0
2023 Q3	2	100	$417.00	$0
2023 Q2	2	100	$315.00	$0
2023 Q1	3	103	$457.00	$0
2022 Q4	31	1.63 M	$534 k	$154 k
2022 Q3	33	1.73 M	$1.12 M	$318 k
2022 Q2	39	2.03 M	$1.52 M	$377 k
2022 Q1	45	2.42 M	$4.50 M	$940 k
2021 Q4	50	3.68 M	$10.6 M	$749 k
2021 Q3	46	5.00 M	$25.6 M	$1.67 M
2021 Q2	55	6.54 M	$31.9 M	$865 k
2021 Q1	72	8.93 M	$45.4 M	$418 k
2020 Q4	67	10.3 M	$50.8 M	$0
2020 Q3	66	16.8 M	$405 M	$0
2020 Q2	66	16.5 M	$639 M	$0
2020 Q1	52	13.5 M	$468 M	$0
2019 Q4	41	13.0 M	$595 M	$0